Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: A cluster-randomised controlled trial
Open accessThe DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
BACKGROUND: Agitation is a common, challenging symptom affecting large numbers of people with dementia and impacting on quality of life (QoL). There is an urgent need for evidence-based, cost-effective psychosocial interventions to improve these outcomes, particularly in the absence of safe, effective pharmacological therapies. This study aimed to evaluate the efficacy of a person-centred care and psychosocial intervention incorporating an antipsychotic review, WHELD, on QoL, agitation, and antipsychotic use in people with dementia living in nursing homes, and to determine its cost. METHODS AND FINDINGS: This was a randomised controlled cluster trial conducted between 1 January 2013 and 30 September 2015 that compared the WHELD intervention with treatment as usual (TAU) in people with dementia living in 69 UK nursing homes, using an intention to treat analysis. All nursing homes allocated to the intervention received staff training in person-centred care and social interaction and education regarding antipsychotic medications (antipsychotic review), followed by ongoing delivery through a care staff champion model. The primary outcome measure was QoL (DEMQOL-Proxy). Secondary outcomes were agitation (Cohen-Mansfield Agitation Inventory [CMAI]), neuropsychiatric symptoms (Neuropsychiatric Inventory-Nursing Home Version [NPI-NH]), antipsychotic use, global deterioration (Clinical Dementia Rating), mood (Cornell Scale for Depression in Dementia), unmet needs (Camberwell Assessment of Need for the Elderly), mortality, quality of interactions (Quality of Interactions Scale [QUIS]), pain (Abbey Pain Scale), and cost. Costs were calculated using cost function figures compared with usual costs. In all, 847 people were randomised to WHELD or TAU, of whom 553 completed the 9-month randomised controlled trial. The intervention conferred a statistically significant improvement in QoL (DEMQOL-Proxy Z score 2.82, p = 0.0042; mean difference 2.54, SEM 0.88; 95% CI 0.81, 4.28; Cohen's D effect size 0.24). There were also statistically significant benefits in agitation (CMAI Z score 2.68, p = 0.0076; mean difference 4.27, SEM 1.59; 95% CI -7.39, -1.15; Cohen's D 0.23) and overall neuropsychiatric symptoms (NPI-NH Z score 3.52, p < 0.001; mean difference 4.55, SEM 1.28; 95% CI -7.07,-2.02; Cohen's D 0.30). Benefits were greatest in people with moderately severe dementia. There was a statistically significant benefit in positive care interactions as measured by QUIS (19.7% increase, SEM 8.94; 95% CI 2.12, 37.16, p = 0.03; Cohen's D 0.55). There were no statistically significant differences between WHELD and TAU for the other outcomes. A sensitivity analysis using a pre-specified imputation model confirmed statistically significant benefits in DEMQOL-Proxy, CMAI, and NPI-NH outcomes with the WHELD intervention. Antipsychotic drug use was at a low stable level in both treatment groups, and the intervention did not reduce use. The WHELD intervention reduced cost compared to TAU, and the benefits achieved were therefore associated with a cost saving. The main limitation was that antipsychotic review was based on augmenting processes within care homes to trigger medical review and did not in this study involve proactive primary care education. An additional limitation was the inherent challenge of assessing QoL in this patient group. CONCLUSIONS: These findings suggest that the WHELD intervention confers benefits in terms of QoL, agitation, and neuropsychiatric symptoms, albeit with relatively small effect sizes, as well as cost saving in a model that can readily be implemented in nursing homes. Future work should consider how to facilitate sustainability of the intervention in this setting. TRIAL REGISTRATION: ISRCTN Registry ISRCTN62237498.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Since the 2017 Commission two new systematic reviews of antidepressants to treat depression in dementia reported moderate quality evidence that antidepressant treatment for people with dementia does not lead to better control of symptomatology compared with placebo.214, 215”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [214]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,039
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Cornell scale for depression in dementia
Alexopoulos, G. S., Abrams, R. C., Young, R. C., & Shamoian, C. A. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90038-8 · Cited by 2,678
Schneider, L. S., Dagerman, K. S., & Insel, P. (2005) · JAMA · doi:10.1001/jama.294.15.1934 · Cited by 1,671
A Description of Agitation in a Nursing Home
Cohen-mansfield, J., Marx, M. S., & Rosenthal, A. S. (1989) · Journal of Gerontology · doi:10.1093/geronj/44.3.m77 · Cited by 1,349 · cited 11×
“A sub-group analysis was also undertaken comparing the WHELD intervention in people with mild to moderate (FAST 4–5), moderately severe (FAST 6), and severe (FAST 7) dementia, focusing on the primary and key secondary outcomes (DEMQOL, CMAI, and NPI-NH).”
MethodInfluentialEffectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease
Schneider, L. S., Tariot, P. N., Dagerman, K. S., Davis, S. M., Hsiao, J. K., Ismail, M. S., Lebowitz, B. D., Lyketsos, C. G., Ryan, J. M., Stroup, T. S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061240 · Cited by 1,206 · cited 3×
“Benefits from pharmacological treatment with atypical antipsychotics are limited to modest improvements in aggression [12,13,15], and the significant advantage on the CMAI for the WHELD intervention compared to control is comparable to the modest treatment advantage for atypical antipsychotics from a meta-analysis of…”
BackgroundResultA Metaanalysis of Controlled Trials of Neuroleptic Treatment in Dementia
Schneider, L. S., Pollock, V. E., & Lyness, S. A. (1990) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1990.tb02407.x · Cited by 650 · cited 1×
“The findings are particularly favourable when compared with those of trials of antipsychotic medications, which show only very modest benefits over 12 weeks in the context of significant harms [41,42].”
Result
Cited by
Items 201–260 of 260
“Life is for living” : exploring thriving for older people living in nursing homes
Baxter, R. (2021) · DiVA at Umeå University (Umeå University) · Cited by 1
King, R., Warren, S., Vass, E., Sharpe, B. T., Beaumont, K., Seymour, S., Bell, S., & Pereira, A. (2026) · medRxiv · doi:10.64898/2026.01.10.26343830 · Cited by 1
Futuristic prevention science and therapeutic conversations
Bhui, K. S. (2018) · The British Journal of Psychiatry · doi:10.1192/bjp.2018.57
Apuntes del diario de un médico que soñaba con el modelo centrado en el paciente
Moral, E. G. (2018) · Folia Humanística · doi:10.30860/0043
Unpicking the costs of dementia care in care homes
Cullum, S. J., & Comas‐Herrera, A. (2020) · International Psychogeriatrics · doi:10.1017/s104161022000023x · Cited by 1
“…more severe dementia, and was also cost-saving as the overall health and social care International Psychogeriatrics (2020), 32:3, 307–309 © International Psychogeriatric Association 2020 doi:10.1017/S104161022000023X costs were lower in people allocated to the intervention (Ballard et al., 2018).”
BackgroundInfluentialSurvival and community care use by care home residents in England: does mental health matter?
Tsiachristas, A., Broad, A., Coates, A., Singh, S. U., & Fossey, J. (2021) · Ageing and Society · doi:10.1017/s0144686x21001148 · Cited by 1
“…the majority of care home residents, it is essential that care home settings meet the needs of people with dementia (Kane and 1100 A Tsiachristas et al. Terry, 2015) and provide effective interventions to improve the quality of life of people with dementia in care homes (Ballard et al., 2018).”
BackgroundSelf-citation[Pharmaceutical care of the geriatric patient in the hospital].
Kniggendorf, K., Klima, K., Krolop, L., Zerres, M., & Jaehde, U. (2013) · PubMed
Kaplan, D. B. (2020) · Oxford University Press eBooks · doi:10.1093/obo/9780195389678-0281
Bhoopatiraju, S., & Grossberg, G. T. (2022) · touchREVIEWS in Neurology · doi:10.17925/usn.2022.18.1.7
Meta Analysis of Intervention Effect of Hospice Care on Senile Dementia Patients
乔, 疏. (2022) · Nursing Science · doi:10.12677/ns.2022.115110
Exploring person-attuned musical interactions in dementia care: A flexible design
Krøier, J. K. (2022) · VBN Forskningsportal (Aalborg Universitet) · doi:10.54337/aau510597389 · Cited by 5
Dalgarno, L., Birt, L., Bond, C. M., Blacklock, J., Blyth, A., Inch, J., Notman, F., Daffu-O’Reilly, A., Spargo, M., Watts, L., et al. (2023) · SSM - Qualitative Research in Health · doi:10.1016/j.ssmqr.2023.100254 · Cited by 1
You, S. Y. (2023) · NPG. Neurologie, psychiatrie, gériatrie/NPG · doi:10.1016/j.npg.2023.05.003
Dementias Conference 2024: session summaries
Rajagopalan, U. (2024) · British Journal of Neuroscience Nursing · doi:10.12968/bjnn.2024.20.2.72
Use of Trazodone in the Management of Psychomotor Agitation in Dementia Syndromes
Meneghelli, B. B., de Almeida, B. V., Francio, B., Pandolphi, M., Brito, T. D. S., Amaral, A. F. M., Lima, J. A. R., Ruiz, G. S. M., Pinto, R. A. C., Scaffi, M. H., et al. (2024) · International Journal of Health Science · doi:10.22533/at.ed.1594962429103
“Those Terrible Men Have Left”: Agitation in MNCD
Gibfried, M., & Grossberg, G. T. (2024) · Cambridge University Press eBooks · doi:10.1017/9781108630344.010
Living with Dementia and Cognitive Disorders: Beyond Pharmacology
Cohen‐Mansfield, J. (2024) · Topics in Geriatric Care. · doi:10.1007/978-981-97-5995-8_9
Vicente-Alba, J., Gutiérrez-Botella, J., García-Mahía, C., & Mateos, R. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1481898
Møtet med demenspasienten lærte meg hva personsentrert omsorg er
Lauten, B. M. (2025) · Sykepleien Forskning · doi:10.4220/sykepleiens.2025.98314
Personsentrert omsorg gir pasienter med demens en verdig hverdag
Halland, A. N. (2025) · Sykepleien Forskning · doi:10.4220/sykepleiens.2025.98385
Yan, S., Delanerolle, G., Gardner, N., Harper, L., Lea, H., Shi, J. Q., & Litchfield, I. J. (2025) · Research Square · doi:10.21203/rs.3.rs-6079038/v1
Non-Pharmacological Approaches to Managing Dementia-Related Anxiety and Agitation
Chigurupati, M. (2023) · International Journal of Multidisciplinary Research and Growth Evaluation · doi:10.54660/.ijmrge.2023.4.1.1041-1048
Ying, M., Cheng, Z., Hirth, R. A., Maddox, K. E. J., & Li, Y. (2025) · Journal of Applied Gerontology · doi:10.1177/07334648251333496 · Cited by 1
“…many SNFs in the US lack the necessary staff and expertise to effectively assess and manage the complex clinical conditions of ADRD patients (Bunn et al., 2014), and address their behavioral symptoms (Ishii et al., 2012) and other special care needs (Ballard et al., 2018; Mukamel et al., 2023).”
Kenny, K., Odell‐Miller, H., & Hsu, M. (2025) · Geriatric Nursing · doi:10.1016/j.gerinurse.2025.04.018 · Cited by 1
Erkes, J., Madiouni, C., Bourgeois, C., Edvardsson, D., Vitou, V., & Bayard, S. (2025) · International Journal of Older People Nursing · doi:10.1111/opn.70032 · Cited by 2
Milieu Therapy in Patients with Dementia
Kwak, Y. T., & Yang, Y. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15060222
Person-Zentrierung in der stationären Altenhilfe: Eine qualitative Dokumentenanalyse von Leitbildern
Hoffmann, A. L., Rommerskirch‐Manietta, M., Holle, B., Palm, R., & Roes, M. (2025) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-025-02443-3
徐, 逸. (2025) · Vechtaer Beiträge zur Gerontologie · doi:10.1007/978-3-658-48005-9_2
Song, J., Yang, Y., Kim, I., Kim, J.-H., Hong, S., & Cheon, H. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5376088
Hüll, M. (2025) · Geriatrie up2date · doi:10.1055/a-2545-8247
Isler, C., Maddigan, J., Burry, R. D., & Gaudine, A. P. (2025) · Issues in Mental Health Nursing · doi:10.1080/01612840.2025.2541245 · Cited by 1
“…improved patient satisfaction (Allerby et al., 2020; Kuipers et al., 2019; Rossom et al., 2016) and improved patient outcomes, including shorter hospital stays and improved functional performance (Fors et al., 2016; Olsson et al., 2013; Wynia et al., 2018; Ballard et al., 2018; Ekman et al., 2011).”
Mehta, I., Dharwadkar, N. P., Bansal, L. R., & Amin, R. (2025) · Journal of Indira Gandhi Institute Of Medical Sciences · doi:10.4103/jigims.jigims_52_25
Communication needs of people with hearing loss and dementia living in care homes
Cross, H. L., & Millman, R. E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29198-2.00003-5
Person-centred care as both a way of thinking and a way of doing
Bravell, M. E., & Johansson, L. (2025) · Evidence-Based Nursing · doi:10.1136/ebnurs-2024-104242
Kwon, C., Kim, J.-W., Oh, J.-W., Jeon, H.-T., Kim, M.-J., Lee, K.-E., Lee, B., Kim, P.-W., & Choi, Y. (2025) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2025.102583
Mjørud, M., Knapskog, A., Nåvik, M., & Røsvik, J. (2025) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000548376
Vislapuu, M., Berge, L. I., Angeles, R. C., Kjerstad, E., Mannseth, J., Achterberg, W. P., & Husebo, B. S. (2022) · Figshare · doi:10.6084/m9.figshare.21483488
Zhang, R., Zhou, Y., Wang, S. L., Li, F., Zhao, X., Jia, B., Li, X., Yang, J., Yang, L., Yu, H., et al. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2025.1710962
Leverton, M., James, T., Samsi, K., Newton, C., & Manthorpe, J. (2026) · Dementia · doi:10.1177/14713012251410977 · Cited by 2
“For example, the WHELD programme withdrew DC support and assessment when the intervention ended (Ballard et al., 2018).”
InfluentialWong, K. L. Y., Hung, L., Wong, J. O. Y., Zhao, Y., Adekoya, A., Chan, I., Wong, J., Berndt, A., Mann, J. I., Yuen, K., et al. (2026) · BMC Geriatrics · doi:10.1186/s12877-026-07263-7 · Cited by 1
“Healthcare providers, such as nurses, physicians, and pharmacists, are trained to understand dementia, the risks of antipsychotic use, and effective alternatives [15, 18, 22, 39, 40, 42, 44, 46, 47, 50–52 , 57–”
InfluentialMushtaq, A., Shah, H. S., Kamran, S. H., Gohar, U. F., Neculoiu, C. D., Podasca, P. C., Moga, M., & Nicolau, A. C. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18030348 · Cited by 2
“The progressive cognitive decline of patients ultimately leads to physical, emotional, behavioral and financial disturbances within their families [8].”
Olazarán, J., Perea, L., Rigueira, A., López‐Álvarez, J., & Múñiz, R. (2026) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2025.106093
Elias, K., & Lood, Q. (2026) · HERD Health Environments Research & Design Journal · doi:10.1177/19375867261431866
“Person-centered care is widely recognized as fundamental to high-quality residential care (Ballard et al., 2018), with documented bene fi ts for well-being and neuropsychiatric symptoms (Kim & Park, 2017).”
Vik‐Mo, A. O. (2026) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2026.10546
Anis-Syakira, J., Balqis-Ali, N. Z., Saw, P. S., Fun, W. H., Sararaks, S., & Lee, S. W. H. (2026) · Family Medicine and Community Health · doi:10.1136/fmch-2024-002967
Construction of an evaluation indicator system for humanistic care quality in nursing homes
Wu, C., Zhang, S., Chen, H., Yu, J., Song, J., Shi, Y., & Shen, Q. (2026) · BMC Geriatrics · doi:10.1186/s12877-026-07623-3
“Ballard et al. found that the implementation of humanistic care interventions for people with dementia in nursing homes improved their quality of life while reducing agitation and neuropsychiatric symptoms [16].”
McPherson, R., Resnick, B. M., Galik, E. M., & Kim, H. (2026) · Geriatric Nursing · doi:10.1016/j.gerinurse.2026.104085
King, R., Warren, S., Vass, E., Sharpe, B. T., Beaumont, K., Seymour, S., Bell, S., Pacella, R., & Pereira, A. (2026) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-026-00782-5
“Similar patterns have been observed in intervention such as the WHELD programme in care home settings, which integrates psychosocial interventions with staff training and has demonstrated improvements in quality of life alongside potential cost offsets [23, 24].”
Park, C. S., & Han, J. W. (2026) · Journal of Cognitive Intervention and Digital Health · doi:10.58558/jcd.2026.5.1.1
Carricondo, I. G., Carricondo, A. R. G., Rey, R. R.-D., & Alarcón, R. (2026) · Healthcare · doi:10.3390/healthcare14131934
“Similarly, complex programs such as WHELD (Well-Being and Health for People with Dementia) [30], Serial Trial Intervention (STI), STA OP!”
Omisore, T., Teeling, S. P., & Frawley, T. (2026) · International Journal of Nursing Studies Advances · doi:10.1016/j.ijnsa.2026.100618
“Notably, the majority of existing research has been conducted with populations living with dementia (Brownie and Nancarrow, 2013; Kim and Park, 2017; Ballard et al., 2018; Berkovic et al., 2024; Chenoweth et al., 2019”
Habibian, S., Huang, G., Wabe, N., Westbrook, J. I., & Nguyen, A. (2026) · Journal of Clinical Nursing · doi:10.1111/jocn.70483
Symptomatic treatment for Alzheimer disease: current evidence and future directions
Ballard, C. G., Doherty, P., Ismail, Z., Corbett, A., & Cummings, J. L. (2026) · Nature Reviews Neurology · doi:10.1038/s41582-026-01260-5 · Cited by 4
“Importantly, several rigorous RCTs with a total of 1,863 participants, combining enjoyable activities or enjoyable exercise with social interaction and person-centred care, have also reported improvements in quality of life, supporting the meaningfulness of these approaches 95,99,100 .”
Self-citationCui, Z., Guan, R. M., Xue, T., Sun, Y., Tan, M. P., Said, M. A., & Cao, Y. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1935007
El futuro de los cuidados de larga duración ante la crisis de la COVID-19
Rodríguez, T. M., & Castiello, M. S. (2021) · Universidad Pontificia Comillas eBooks · doi:10.14422/9788484689034-07 · Cited by 7
Dog-Assisted Interventions for People with Dementia: A Mixed Methods Systematic Review
Pasic, N., Rundgren, M., & Jormfeldt, H. (2026) · Issues in Mental Health Nursing · doi:10.1080/01612840.2026.2729504
Kejžar, A., & Abhayasinghe, K. M. P. W. (2026) · Springer eBooks · doi:10.1007/978-3-032-35691-8_644
Metadata
- Authors
- Ballard, C., Corbett, A., Orrell, M., Williams, G., Moniz-Cook, E., Romeo, R., Woods, B., Garrod, L., Testad, I., Woodward-Carlton, B., Wenborn, J., Knapp, M., & Fossey, J.
- Affiliations
- University of Exeter (GB)
- University of Nottingham (GB)
- King's College London (GB)
- University of Hull (GB)
- Bangor University (GB)
- Oxford Health NHS Foundation Trust (GB)
- University College London (GB)
- London School of Economics and Political Science (GB)
- Corresponding author
- Ballard, Clive
- ORCID
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-02-06
- Volume
- 15
- Issue
- 2
- Pages
- e1002500
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC5800565
- OpenAlex
- W2786082650
- Cited by
- 263
- References
- 42
- Citations by year
- 2026: 31 · 2025: 37 · 2024: 29 · 2023: 30 · 2022: 39 · 2021: 36 · 2020: 30 · 2019: 20 · 2018: 10
- FWCI
- 18.89
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- London School of Economics and Political Science Research Online (London School of Economics and Political Science) (acceptedVersion)
- London School of Economics and Political Science Theses Online (London School of Economics and Political Science) (acceptedVersion)
- Repository@Hull (Worktribe) (University of Hull) (acceptedVersion, other-oa)
- Nottingham ePrints (University of Nottingham) (submittedVersion, cc-by)
- Repository@Hull (Worktribe) (University of Hull) (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
- Funders
- Programme Grants for Applied Research (RP-PG-0608-10133)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Geriatrics and Gerontology › Geriatric Care and Nursing Homes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative Care and End-of-Life Issues
- Keywords
- person-centred care, dementia, nursing homes, agitation, antipsychotic use, psychosocial interventions, employee training, quality of life, neuropsychiatric symptoms, quality of care, cost-effectiveness, unmet needs, pain, depression in dementia, mortality, interaction quality, DEMQOL
- MeSH terms
- Aged, 80 and over, Cost-Benefit Analysis, Dementia, Education, Nursing, Continuing, Female, United Kingdom, Homes for the Aged, Humans, Interpersonal Relations, Male, Nurse-Patient Relations, Nursing Homes, Psychomotor Agitation, Quality of Life, Antipsychotic Agents, Patient-Centered Care, Intention to Treat Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
